article · The Lancet Microbe
Acute rheumatic fever is an immune-mediated sequela of Streptococcus pyogenes (group A Streptococcus) infection, presenting with fever, arthritis, chorea, rash, and, crucially, carditis. Without effective secondary prophylaxis and care, acute rheumatic fever can progress to chronic rheumatic heart disease, a leading yet under-recognised cause of cardiovascular morbidity and death that disproportionately affects children and young adults aged 5-24 years in low-resource settings. Robust evidence implicates the role of antigenic mimicry-particularly between streptococcal M protein and cardiac or myocardial matrix proteins-together with dysregulated immune control in driving valvular injury. In this Review, we discussed mechanisms of rheumatic heart disease immunopathogenesis, highlighting the roles of T-cell responses, chemokine-guided recruitment to valves, cytokine dysregulation, endothelial activation, and stromal remodelling. We also analysed limitations of existing data and delineate strategies to develop experimental models, identify biomarkers, and define immunomodulatory targets that can inform earlier diagnosis, enhanced secondary prevention, and rational therapeutic strategies.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.lanmic.2026.101499
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.